A PYMNTS Company
GlaxoSmithKline

GSK Acquires Sierra For $1.9B

GlaxoSmithKline is acquiring California biopharmaceutical firm Sierra Oncology for $1.9 billion in a deal expected to help both companies take a major step in developing

Read More »
Scroll to Top